Blog Posts in July, 2012

Fresenius Recall - Naturalyte and Granuflo

If you’ve recently undergone dialysis, you might have been given the recalled dialysates Naturalyte or Granuflo. Both dialysates were recalled by the FDA on June 27, 2012. Experts estimate that over ...
Continue Reading +

More Transvaginal Mesh Taken Off of the Market

After the Food and Drug Administration (FDA) ordered C.R. Bard to conduct clinical trials on the Avaulta transvaginal surgical mesh, C.R. Bard was to prepare a study proposal for FDA approval. ...
Continue Reading +

Pradaxa Blows Away the Field in 2011 FDA Adverse Drug Events

2011 was Pradaxa’s first full year on the United States prescription drug market. Last Pradaxa (also known as Dabigatran) generated sales of $829 million dollars in the USA. The drug achieved ...
Continue Reading +

Lines in the Sand: DePuy and Johnson & Johnson Take Hard Line Stance over Pinnacle Metal on Metal Hip Failures

When the DePuy ASR hip crisis escalated in 2010, DePuy Orthopaedics (a Johnson & Johnson subsidiary) took certain measures to assist affected patients, such as setting up a process to handle and ...
Continue Reading +

Johnson & Johnson Ignored FDA Order to Stop Selling Mesh: When Will They Learn?

According to Bloomberg News , Johnson & Johnson continued to sell one of its vaginal mesh implants for nine months after the FDA told it to stop marketing the device. In a letter on August 24, 2007, ...
Continue Reading +

FDA Expects New Bill To Rake $6 Billion

On Tuesday, the senate passed a bill that enables the FDA to assess fees on foreign drug manufacturers and renew fee agreements with domestic makers. The measure is expected to rake $6 Billion over ...
Continue Reading +